Raymed Labs Ltd
Incorporated in 1994, Raymed Labs manufactures pharmaceutical products and injectables for human and animal use.
- Market Cap ₹ 1.02 Cr.
- Current Price ₹ 2.39
- High / Low ₹ 2.46 / 2.04
- Stock P/E
- Book Value ₹ -5.48
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Company has low interest coverage ratio.
- Promoter holding is low: 28.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
0.18 | 0.03 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.06 | 0.07 | 0.08 | 0.19 | 0.15 | |
Operating Profit | 0.00 | -0.03 | -0.03 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.06 | -0.07 | -0.08 | -0.19 | -0.15 |
OPM % | 0.00% | ||||||||||||
-0.04 | -0.02 | -0.02 | 0.02 | 0.00 | -0.01 | -0.02 | -0.02 | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | |
Interest | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation | 0.01 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
Profit before tax | -0.06 | -0.06 | -0.05 | -0.02 | -0.04 | -0.05 | -0.06 | -0.06 | -0.06 | -0.07 | -0.09 | -0.18 | -0.13 |
Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
-0.07 | -0.07 | -0.05 | -0.02 | -0.04 | -0.05 | -0.06 | -0.05 | -0.06 | -0.07 | -0.08 | -0.17 | -0.14 | |
EPS in Rs | -0.16 | -0.16 | -0.12 | -0.05 | -0.09 | -0.12 | -0.14 | -0.12 | -0.14 | -0.16 | -0.19 | -0.40 | -0.34 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | -8% |
Stock Price CAGR | |
---|---|
10 Years: | -13% |
5 Years: | 1% |
3 Years: | 36% |
1 Year: | 17% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 | 4.27 |
Reserves | -5.87 | -5.94 | -5.99 | -6.00 | -6.04 | -6.09 | -6.15 | -6.20 | -6.26 | -6.33 | -6.41 | -6.58 | -6.61 |
2.15 | 2.15 | 1.96 | 2.00 | 1.99 | 2.03 | 2.04 | 2.05 | 2.07 | 2.21 | 0.05 | 0.05 | 0.00 | |
0.08 | 0.04 | 0.06 | 0.04 | 0.06 | 0.07 | 0.11 | 0.14 | 0.18 | 0.10 | 2.33 | 2.42 | 2.49 | |
Total Liabilities | 0.63 | 0.52 | 0.30 | 0.31 | 0.28 | 0.28 | 0.27 | 0.26 | 0.26 | 0.25 | 0.24 | 0.16 | 0.15 |
0.25 | 0.24 | 0.20 | 0.20 | 0.19 | 0.19 | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 | 0.15 | 0.15 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
0.38 | 0.28 | 0.10 | 0.11 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.09 | 0.08 | 0.01 | 0.00 | |
Total Assets | 0.63 | 0.52 | 0.30 | 0.31 | 0.28 | 0.28 | 0.27 | 0.26 | 0.26 | 0.25 | 0.24 | 0.16 | 0.15 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.03 | -0.04 | 0.11 | -0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.21 | -0.16 | |
0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.21 | 0.16 | |
0.02 | 0.00 | -0.17 | 0.03 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Cash Flow | 0.05 | -0.04 | -0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 263.61 | |||||||||||
Inventory Days | 0.00 | |||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 263.61 | |||||||||||
Working Capital Days | 425.83 | |||||||||||
ROCE % | -1.64% | -7.77% | -2.78% | -7.84% | -8.16% | -13.95% | -16.22% | -21.43% | -60.00% | -60.87% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
17 Apr - Outcome of Board Meeting pursuant to under Regulation 30 of SEBI (LODR) Regulations, 2015- change in Registered office of the Company within Local Limits
-
Compliance Under Reg. 40(9) Of SEBI (LODR) Regulations, 2015
15 Apr - Compliance under Reg. 40(9) of SEBI (LODR) Regulations, 2015 for the year ended 31 March, 2024
-
Compliance Certificate For The Year Ended March 31, 2024
13 Apr - Compliance Certificate under Regulation 7(3) of SEBI (LODR) Regulations, 2015 for the year ended 31 March, 2024
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 13 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31 March, 2024
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 1999
from bse
Business Overview:[1]
Company is engaged in the business of manufacturing, importing, exporting, trading, distributing, and dealing in pharmaceuticals, medicals, chemicals, industrial and other preparations and articles, compound, drugs, veterinary and human medicines, crude drugs, packing material and containers.